Other news

Demonstrated a new beneficial effect of bempedoic acid in an experimental rat model of non-alcoholic fatty liver disease. This drug has been approved for use in humans for the treatment of hypercholesterolemia

A study led by the IBUB team of Juan C. Laguna, Professor of Pharmacology at Universitat de Barcelona, demonstrates a new beneficial effect of bempedoic acid in an experimental model of rats with non-alcoholic fatty liver disease. This drug has been approved for use in humans in the treatment of hypercholesterolemia. The pathology of non-alcoholic

6 Predoctoral Fellowship (FPI)

The IBUB is seeking ealry stage researchers interested in pursuing their PhD in any of our research programs. Program 1. Metabolism and cell plasticity Program 2. Human genetics and disease Program 3. Drug and Target Discovery If you are interested please contact our Principal Investigators or directly with us at ibub@ub.edu. Please send us your

The “Molecular Metabolism and Disease” team leads dissemination activities in “The Day of Obesity” organized by SEEDO, to highlight the importance of brown fat research to combat obesity effectively

The Spanish Society of Obesity (SEEDO) organized the “The Day of Obesity” in Spain last December 15. A highlight was dissemination of the importance of research on brown adipose tissue activity, why it is protective against obesity and associated diseases, and how current research envisage the identification of new tools for therapeutic activation of brown

The research team of Dr. Eva Estébanez-Perpiñá, from IBUB, reveals the extraordinary plasticity of the glucocorticoid receptor

Glucocorticoids —such as cortisone— are among the most widely used anti-inflammatory drugs, and are used to treat asthma, psoriasis, organ transplantation and even COVID-19. Regarding their pharmacological action, the activity of the glucocorticoid receptor (GR) is crucial. The GR is a transcription factor that regulates vital processes in human physiology. However, the detailed three-dimensional structure

Symposium on Genetic Rare Diseases

On November 7, the IBUB/UB-CIBERER Mini Symposium on Genetic Rare Diseases was held in Barcelona. In a face-to-face and online format, four speakers have walked the path from the patient affected by a rare disease, who is visited by clinical experts in search of a diagnosis (Merche Serrano, Hospital Sant Joan de Déu and CIBERER),

La Marató 2021 endorses two IBUB research projects on mental health

In 2021, La Marató de TV3 and Catalunya Ràdio was dedicated to mental health in order to raise public awareness of disorders with many stigmas, and it raised 12.1 million euros. Now, these funds will be used to promote 36 research projects led by 81 research teams. The ceremony took place on Thursday 3 November

CDF15 cytokine, a promising therapeutic target against type 2 diabetes

A team led by Professor Manuel Vázquez-Carrera, researcher from IBUB of Faculty of Pharmacy and Food Sciences (UB), has conducted a review study on the Growth Differentiation Factor 15 (GDF15) —a protein expressed under physiological stress conditions— and its potential impact on the treatment for type 2 diabetes. The study, published in the journal Trends

8th International Annual Meeting: “Metabolism and disease: new perspectives

8th International Annual Meeting: “Metabolism and disease: new perspectives” will take place at Sala Pi i Sunyer, Institut d’Estudis Catalans (Carrer del Carme, 47. Barcelona) on October 17th and 18th, 2022. https://scb.iec.cat/8th-metnet-international-annual-meeting-2022/ The conference will host well-known speakers within different areas of metabolism and their approaches to unveiling metabolic dysregulation in disease progression. But this